Overview
Guy Marks practices in Glebe, Australia. Mr. Marks is rated as an Experienced expert by MediFind in the treatment of Bronchiectasis. His top areas of expertise are Asthma, Asthma in Children, Chronic Obstructive Pulmonary Disease (COPD), and Pulmonary Tuberculosis.
His clinical research consists of co-authoring 351 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Bronchiectasis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AsthmaMr. Marks isElite. Learn about Asthma.
- Distinguished
- Asthma in ChildrenMr. Marks isDistinguished. Learn about Asthma in Children.
- Chronic Obstructive Pulmonary Disease (COPD)
- Pulmonary TuberculosisMr. Marks isDistinguished. Learn about Pulmonary Tuberculosis.
- Advanced
- Eosinophilic AsthmaMr. Marks isAdvanced. Learn about Eosinophilic Asthma.
- StridorMr. Marks isAdvanced. Learn about Stridor.
- Experienced
- Allergic RhinitisMr. Marks isExperienced. Learn about Allergic Rhinitis.
- Atopic DermatitisMr. Marks isExperienced. Learn about Atopic Dermatitis.
- BronchiectasisMr. Marks isExperienced. Learn about Bronchiectasis.
- Common ColdMr. Marks isExperienced. Learn about Common Cold.
- Conjunctivitis (Pink Eye)Mr. Marks isExperienced. Learn about Conjunctivitis (Pink Eye).
- COVID-19Mr. Marks isExperienced. Learn about COVID-19.